Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Document › Details

Helmholtz-Zentrum für Infektionsforschung (HZI. (11/10/14). "Press Release: Breakthrough Prize in Life Sciences for Emmanuelle Charpentier. HZI Researcher Honoured for Discovery of CRISPR-Cas9 System".

Organisations Organisation Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
  Group Helmholtz-Gemeinschaft (HGF) (Group)
  Organisation 2 Umeå University
  Group Abbvie Spain S.L.U.
Products Product CRISPR gene editing technology
  Product 2 genomic technology
Person Person Charpentier, Emmanuelle (Helmholtz 201412 Professor at HZI)

One of this year’s Breakthrough Prizes in Life Sciences was bestowed to HZI researcher Prof. Emmanuelle Charpentier. The twelve prizes, each endowed with 3 Million US dollars, were awarded on 9 November in Silicon Valley. Charpentier is head of the research department “Regulation in Infection Biology” at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, holds an Alexander von Humboldt professorship at Hannover Medical School (MHH) and also leads a research group at the Laboratory for Molecular Infection Medicine Sweden (MIMS) in Umea, Sweden. The Frenchwoman is one of the discoverers of the CRISPR-Cas9 system, a biotechnological tool for targeted genome editing.

The underlying mechanism was found in bacteria, which use it to protect themselves from viruses. They recognise specific sequences and are capable of cleaving viral genomes. Researchers are now using this system in the laboratory to perform targeted interventions in the genetic material of cells. In the future, this technique could be used to cure genetic disorders. Treating HIV infections could be possible as well.

The Breakthrough Prize was initiated by Google founder Sergey Brin and Mark Zuckerberg of Facebook, among others. The prize is awarded for the third time and was created to honour great scientists and their ground-breaking discoveries. Besides Life Sciences, it is also bestowed in Physics and Mathematics.

Emmanuelle Charpentier came to Germany as a Humboldt professor from Sweden in 2013. Her research on the CRISPR-Cas technology has received a lot of attention and recognition lately: In March she received the Göran Gustaffson Award of the Royal Swedish Academy of Sciences and was elected to become a member of the European Molecular Biology Organisation (EMBO) in May. She received the Dr Paul Janssen Award for Biomedical Research from the pharmaceutical company Johnson & Johnson in September. Recently, she was given the Jacob Heskel Gabbay Award from Brandeis University in Massachusetts.

More information about the prize and the other awardees on

Record changed: 2017-04-02


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Helmholtz-Gemeinschaft (HGF) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top